Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13063-018-2957-0/MediaObjects/13063_2018_2957_Fig2_HTML.png)
Registration and results reporting status of trials supporting FDA indications by FDAAA applicability, 2005–2014. Post-FDAAA trials were significantly more likely to be registered (100% vs 64%; p < 0.001) and report results (100% vs 10%; p < 0.001) than pre-FDAAA. Outcomes were compared by two-tailed Fisher exact tests